Skip to main content
NIH funding notice RFA-HD-19-001

Safe and Effective Devices for Use In Neonatal, Perinatal and Pediatric Care Settings (R43/R44 Clinical Trial Optional)

Closed on August 1, 2018.

Posted
March 5, 2018
Close date
August 1, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $426,653 in first-year total cost, median $213,327.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 EMNR-W (56)]2

Most frequent institutions

  1. MOTHER'S MILK IS BEST, INC.1
  2. PRETEL, INC.1
Competing awards under RFA-HD-19-001 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2019Human Milk Concentration Device; Point of Care Technology for Feeding Preterm Infants in Intensive Care1R43HD098737-01NELSON, ELIZABETH RANDALLSCHINKEL, ELIZABETH RINALDIMOTHER'S MILK IS BEST, INC., MA$223,627ZRG1
2019Identifying the precursor to oxytocin-induced uterine tachysystole by monitoring with uterine EMG1R43HD098730-01YOUNG, ROGER C.PRETEL, INC., TN$203,026ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.